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ABSTRACT
INTRODUCTION Tobacco smoking is a significant public health threat in 
the world, a risk factor for many diseases, and has been increasing in 
prevalence in many developing countries. In this study, we aimed to 
estimate the burden of premature deaths attributable to smoking among 
Tunisian men aged 35–69 years in 2009.
METHODS The number of deaths attributable to smoking was estimated using 
the population attributable risk fraction method. Smoking prevalence 
was obtained from a nationally representative survey. Causes of death 
were obtained from the registry of the National Public Health Institute. 
Relative risks were taken from the American Cancer Society Prevention 
Study (CPS-II).
RESULTS Total estimated premature deaths attributable to smoking among 
men in Tunisia were 2601 (95% CI: 2268–2877), accounting for 25% 
(95% CI: 23.3–26.6) of total male adult mortality. Cancer, cardiovascular 
and respiratory diseases were the major causes of premature deaths 
attributable to smoking with 1272 (95% CI: 1188–1329), 966 (95% CI: 
779–1133) and 364 (300–415) deaths, respectively.
CONCLUSIONS Tobacco smoking is highly relevant and is related to substantial 
premature mortality in Tunisia, around double that estimated for the 
region as a whole. This also has not decreased over the past 20 years. 
Urgent actions are needed to reduce this pandemic.
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INTRODUCTION
Tobacco smoking has been estimated to be the second 
leading risk factor for death from all causes1-3, and 
it is the leading cause of preventable death (death 
at ages <70 years) in the world. According to the 
World Health Organization (WHO), tobacco use 
results in about 6 million deaths per year and this 
number will increase to more than 8 million per year 
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by 2030. More than 80% of those deaths will occur 
in low- and middle-income countries4, and many at 
early ages. The number of premature deaths (death 
at ages 30–69 years) was estimated at 4·83 million in 
2000. Ezzati et al.3 estimated that only half of these 
deaths were registered in developing countries. The 
number of smoking-attributable deaths will increase 
considerably in these countries during the next few 
decades3. In 2010, 8.4% of the worldwide burden of 
diseases in men were attributed to tobacco smoking 
(including secondhand smoke), which made smoking 
the leading risk factor for death in men, while this 
proportion was 3.7% in women (fourth highest risk 
factor)5. According to the Global Burden of Disease 
group, smoking was the fourth most crucial risk factor 
in terms of Disability-Adjusted Life Years (DALYs) 
after dietary risks, high blood pressure and high body 
mass index6, in Tunisia. 
In many developed countries, the proportion of 
deaths attributed to smoking increased from 10.3% 
to 22.3% in men, and from 0.7% to 8.1% in women 
between 1955 and 20007. In Tunisia, smoking 
prevalence in men has been very high for some 
time. In 1997, 30.5% of adults were current smokers 
(55.8% in men and 5.3% in women), while more 
recent studies have confirmed that these smoking 
rates remain broadly constant in men (55.2%)8,9. The 
burden of deaths attributable to smoking in men in 
Tunisia is hence likely to be high, but no estimate of 
this has been made since 199710,11. The purpose of 
our study was to estimate the burden of premature 
deaths attributable to smoking among Tunisian men 
aged 35–69 years in 2009.
METHODS 
The number of deaths was estimated using the 
WHO methodology, which requires data on smoking 
prevalence, causes of deaths, population size and 
relative risks12 (Table 1).
Smoking prevalence
Smoking prevalence was obtained from the 
Epidemiological Transition and Health Impact in 
North Africa (TAHINA) survey. This was conducted 
in Tunisia in 2005 and included a nationally 
representative sample of 8007 individuals, aged 
35–70 years13.  ‘Smoker’ was defined as someone 
who reported smoking cigarettes daily for at least 
the month previous to the survey. ‘Former smokers’ 
were defined as adults who have smoked in their 
lifetime but report that they do not currently smoke. 
We assumed that smoking prevalence in 2009 would 
have been approximately the same as in 2005. 
This assumption seems reasonable since smoking 
prevalence in adult men has remained mostly constant 
for the past ten years9.
Causes of death
Tunisian population estimates and number of deaths 
(distributed by age and sex) were obtained from 
the National Institute of Statistics14; while causes 
of death in 2009 were obtained from the Tunisian 
causes of death surveillance system (National Institute 
of Public Health, Ministry of Public Health), which 
uses the international death certificate model . Causes 
of death were coded according to the 10th revision 
of International Classification of Diseases (ICD10), 
using the STYX Software15. All deaths are recorded in 
Tunisia, and cause of death confirmed by a clinician 
is available for about 50% of the total. Based on the 
ANACONDA tool applied to Tunisian data in 2013, 
the weighted scores of the quality of cause of death 
Age group 
(years)
Non-smokers*
%
Former smokers*
%
Current smokers*
%
Population**
( 1000 )
Deaths**
n
35–39 26.2 14.7 59.1 347 587
40–44 29.8 17.8 52.5 340 809
45–49 29.0 18.4 52.6 320 980
50–54 30.0 26.5 43.4 280 1546
55–59 21.6 31.3 47.1 208 1937
60–64 34.9 25.7 39.4 138 1977
65–69 35.5 37.3 27.3 122 2613
Total 29.0 22.3 48.7 1756 10449
Table 1.  Population sizes, number of deaths and smoking prevalence in men aged 35–69 years in Tunisia, 2009
Sources: * TAHINA Survey, **National Institute of Statistics.
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reporting, quality of age and sex reporting, the level 
of cause-specific detail available, are 72.2, 91.3 and 
90.3, respectively16.
We assumed that the causes of death by age were 
the same amongst those deaths with and without a 
classified cause. We applied the per cent of causes of 
deaths by gender and age groups to the total deaths 
registered in Tunisia. Premature mortality was defined 
as deaths occurring in the age group 35–69 years. 
Population data 
The Tunisian male population aged ≥35 years 
was obtained from Tunisian National Institute of 
Statistics for 2009. In 2009, the Tunisian population 
was approximately 10 million, and there were 1.756 
million men aged 35–69 years (33.7% of the total 
population of men). In this same year, there were 
10449 deaths among men aged 35–69 years14.
Relative risks and mortality attributable to 
smoking
Relative risks for specified causes of death among 
both current and former smokers of cigarettes, for 
men aged ≥35 years, were taken from the American 
Cancer Society Prevention Study (CPS-II)17 (Table 2).
The number of deaths was estimated using 
population attributable risk fraction, by specific 
causes and age groups, based on Levin’s formula18. 
Calculations were performed in MS Excel (Table 2). 
For sensitivity analyses, we used the upper and lower 
bounds of the 95% confidence intervals (CIs) for the 
prevalence of current and former smoking (from our 
own TAHINA surveys) and upper and lower values for 
relative risk (obtained from the US CPS-II dataset). 
RESULTS 
In 2009, the crude mortality rate was 595 per 100000 
among men aged 35–69 years. Figure 1 summarizes 
the leading causes of premature mortality among men 
in Tunisia, which were lung cancer (64 per 100000) 
followed by chronic heart diseases (60 per 100000) 
and cerebrovascular disorders (44 per 100000). The 
estimated number of premature deaths attributable to 
smoking among men was 2601 (95% CI: 2268–2877), 
corresponding to 25% (95% CI: 23.3–26.6) of the 
total number of premature deaths for men (Figure 2). 
Diseases % Deaths Current 
smoker
Former
smoker
Smoking 
attributable 
mortality
Proportion 
attributable
n RR RR n ( 95% CI) n ( 95% CI)
Cardiovascular
Chronic heart 10.1 1057 1.94 1.41 375 (327–418) 35.4 (30.9–39.5)
Cerebrovascular 7.4 777 2.24 1.29 311 (236–378) 40.1 (30.3–48.6)
Other circulatory 0.5 53 4.06 2.33 34 (29–39) 64.1 (53.9–72.2)
Other heart 7.2 752 1.85 1.32 246 (188–299) 32.7 (24.9–39.7)
All 25.3 2639 – 966 (779–1133) -
Respiratory
Chronic obstructive 
pulmonary 
2.7 281 9.65 8.75 241 (226–252) 85.6 (80.3–89.5)
Other 3.1 325 1.99 1.56 123 (74–164) 37.8 (22.7–50.4)
All 5.8 606 – 364 (300–415) -
Cancers
Lip, oral cavity, pharynx 1.0 105 27.48 8.80 98 (87–102) 93.6 (82.7–97.6)
Esophagus 0.3 36 7.60 5.83 29 (23–32) 81.1 (64.1–90.2)
Pancreas 1.1 120 2.14 1.12 44 (25–60) 36.8 (20.5–50.16)
Larynx 0.3 27 10.48 5.24 23 (16–26) 84.8 (58.8–94.63)
Lung 10.7 1118 22.36 9.36 1034 (1012–1052)) 92.5 (90.5–94.0)
Kidney 0.0 0 2.95 1.95 0 –
Bladder, other urinal 0.8 83 2.86 1.90 44 (26–57) 52.5 (31.5–67.8)
All 14.3 1490 1272 (1188–1329) -
All causes 4735 2601 (2268–2877)
Table 2. Mortality attributable to smoking in men in Tunisia, 2009
RR: Risk Ratio.
Research Paper
Tobacco Induced Diseases 
Tob. Induc. Dis. 2019;17(November):77
https://doi.org/10.18332/tid/112666
4
Cancer, cardiovascular disease and respiratory 
diseases were the major causes of premature death 
attributable to smoking accounting for 1272 (95% CI: 
1188–1329), 966 (95% CI: 779–1133) and 364 (95% 
CI: 300–415) deaths, respectively [48.9% (95% CI: 
46.2–51.7), 37.1% (95% CI: 34.4–40.4) and 14.0% 
(11.8–16.2)], as outlined in Table 2.
Deaths attributable to smoking applying a 
sensitivity analysis (minimum-maximum) 
In 2009, 93.6% (95% CI: 82.7–97.6) of deaths caused 
by lip, oral cavity and pharynx cancers among men 
aged 35–64 years were attributable to smoking. Lung 
cancer had a high attributable risk associated with 
smoking among men [92.5% (95% CI: 90.5–94.0) 
of lung cancer deaths], the chronic heart disease 
[35.4% (95% CI: 30.9–39.5) of chronic heart disease 
deaths], cerebrovascular disorders [40.1% (95% CI: 
30.3–48.6) of cerebrovascular disorders deaths] 
and chronic obstructive pulmonary disease [85.6% 
(95% CI: 80.3–89.5)]. These diseases accounted 
for approximately 76.0% of total premature deaths 
attributable to smoking among men (Table 2).
DISCUSSION
This study showed that tobacco smoking in 2009 
was responsible for about a quarter (2601 deaths) 
of premature deaths among Tunisian men. This 
could well confirm the propagation of the tobacco 
epidemic for men in Tunisia, referring to the Lopez 
et al.19 propagation model of tobacco use epidemic. 
A recent study advocates considering the tobacco 
epidemic separately for men and women, particularly 
in developing countries20, since the factors that lead 
to the start and continuation of cigarette smoking and 
tobacco use may be different for women than for men, 
and may also differ between developed and developing 
countries. However, in fact, the smoking status of 
women in Tunisia seems to be almost similar to that in 
Western countries during the middle of 20th century 
Figure 2. Deaths attributable to smoking among men aged 35-69 years in Tunisia in 2009
Figure 1. Mortality rates per 100000 by causes among men aged 35-69 years in 2009
Sources: National Institute of Statistics and National Public Health Institute, Tunisia.
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with a substantial decrease in societal and cultural 
prohibition of cigarette smoking among women.
These estimates for 2009 were slightly lower than 
the previous ones of 1997 in Tunisia reported by 
Fakhfakh et al.10 who estimated that 6435 deaths 
occurred because of tobacco smoking in adults, 
amounting to 22% of total male deaths. However, the 
comparison of the two studies must be interpreted 
with caution due to methodological differences. 
The earlier study used the distribution of deaths 
by causes published by WHO in 1998 since the 
Tunisian information system on causes of death was 
not available at that time. Moreover, the earlier study 
included younger men aged >25 years, and all tobacco 
types (the use of other types of tobacco in Tunisia is 
about 1.5%)10. Nevertheless, our calculated proportion 
of smoking-attributable mortality was over twice that 
estimated by WHO for the Eastern Mediterranean 
region (12% for adult men), and it also exceeds that 
of China (12.9% among men)21, but not of western 
countries such France (33%). Our estimate is close 
to some low- and middle-income countries such as 
India (20% for men aged 30–69 years in 2010)12,22,23.
Our results established that the leading causes 
of premature deaths from smoking were cancers, 
cardiovascular diseases and respiratory diseases. 
This is in line with findings from other studies, e.g. 
US in 200424. Ezzati and Lopez3 also estimated that 
lung cancer was the disease with the highest fraction 
attributable to smoking worldwide in 2000. Almost 
three quarters (71.0%) of all lung cancers or 0·85 
million deaths (79.0% or 0·69 million deaths among 
men and 48% or 0·16 million deaths among women) 
were attributable to smoking7. Thus, lung cancer 
mortality is the most specific indicator of tobacco 
smoking effects on health at the population level25. 
Cancer is the second leading cause of death globally, 
with about 70% occurring in low- and middle-income 
countries26. The most common is lung cancer27. Due 
to reduced survival, the main burden of lung cancer 
is due to premature mortality rather than long-term 
illness. Lung cancer was the leading cause of cancer-
related premature mortality among males (20%)28. 
In comparison, in Eastern Morocco, lung cancer 
ranked the fourth most common cancer, accounting 
for 7.5% of total cancers and the most frequent 
malignancy with 19% of male cancers29. In Algeria, 
lung cancer is the sixth most common type of cancer 
(2.8%), and it is the most prevalent cancer in males 
representing 19.9% of cases30.
About one-third of deaths from cancer are due to 
the 5 leading behavioral and dietary risks: tobacco 
use is the most critical risk factor for cancer and is 
responsible for approximately 22% of cancer deaths31. 
The mortality rate of deaths from lung cancer 
almost doubled from 34.8 per 100000 to 58.8 per 
100000 among Tunisian men between 1997 and 
2009 (reflecting the alarming situation of mortality 
and morbidity related to tobacco use in Tunisia)9. 
Unless steps are taken to reduce cigarette smoking, 
the coming decades will experience a significant 
increase in smoking related mortality and morbidity. 
Consequently, the economic burden will be high both 
for the community and also for many of the poorer 
households32. Since tobacco-induced diseases such as 
cancers and cardiovascular diseases are costly, out-of-
pocket expenditure on health care is high in Tunisia. 
In 2010, Tunisia adopted WHO Framework 
Convention on Tobacco Control, and a strategy was 
implemented in 2009, with clear goals, but still modest 
results, due to difficulties with implementation33. 
Since around 1992, several anti-smoking measures 
commenced in Tunisia including information 
campaigns and passing of an anti-smoking law to 
restrict smoking in public places; a decrease in 
tobacco sales has been observed but no decrease in 
smoking prevalence. It is thought that more smokers 
are purchasing cigarettes illegally, with substantial 
increases in tobacco smuggling due to political and 
security problems in Tunisia over the past three years. 
Moreover, smoking cessation interventions should 
be more targeted to high-risk groups to be more 
effective, such as young smokers and females, where 
smoking prevalence trends are highly worrisome34,35.
In this study, reliable data were used. Mortality 
data were obtained from registry of deaths collected 
by the other estimates, e.g. those produced by WHO 
EMRO rely on estimated mortality obtained from 
other countries with similar standards of living and 
development in the Region. This paper is the first 
to use Tunisian data from the national registry that 
records the death certificates. A recent assessment by 
WHO estimated that this mortality database was 87% 
accurate36. Demographic information was provided 
from the census data while the relative risks were 
obtained from CPS-II, an extensive prospective cohort 
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study, used in the majority of studies on smoking-
attributable mortality carried out in both developed 
and developing countries37. CPS-II relative risks 
were calculated in a smoking population consuming 
on average 20 cigarettes per day7, which is similar to 
the Tunisian context (the average daily consumption 
per men was 18±9 cigarettes in 19978 and 20±12 in 
200513). Applying CPS-II relative risks is considered 
appropriate in the absence of extensive prospective 
studies from Tunisia or the Middle East and North 
Africa region (MENA region). 
Strengths and limitations
The key strengths of this analysis include the 
nationally representative data collected through 
TAHINA. Conversely, this study had some limitations. 
The first is related to the fact that in this article, 
smoking prevalence excluded secondhand smoke 
and other types of tobacco use, especially waterpipe 
and chewing tobacco. These types of tobacco 
use are relatively common in Tunisia38, but their 
health impacts and relative risks poorly studied 
and documented39. This exclusion suggests that the 
estimate of tobacco attributable mortality may be 
even higher in Tunisia. Most studies of mortality 
attributable to tobacco have only included cigarette 
smoking and ignored other types of tobacco use, 
except in the Indian Subcontinent where smokeless 
tobacco is particularly common40. Another limitation 
of this study is that we excluded liver and stomach 
cancers in our estimation. Latency may be a limitation, 
as smoking in men in Tunisia has been constant for 
some time and all causes of death that might possibly 
be attributed to smoking were not included.
Another limitation is that we focused on only 
mortality attributable to smoking in men, excluding 
women, even though female smoking is thought 
to be increasing. Unfortunately, there are no data 
considered sufficiently reliable to estimate the 
prevalence of smoking in Tunisian women. The 
current national estimate of 4% is likely to be a 
substantial underestimate6. This is because female 
smoking is still culturally prohibited13. For example, 
the association between lung cancer in women and 
tobacco smoking differs between countries. The 
highest estimates come from North American studies, 
with relative risk near 20, though the lowest come 
from Asian studies24.
CONCLUSIONS 
Cigarette consumption in Tunisian men was 
responsible for 2601 deaths in 2009, one-quarter 
of premature deaths. These estimates of premature 
mortality have significant public health implications. 
The tobacco epidemic in Tunisia is firmly established 
and results in an unavoidable burden of morbidity 
and mortality in Tunisia. In regard to this alarming 
situation, effective interventions to reverse this 
trend were already taken a few years ago; Tunisian 
decision-makers defined a strategy in 2009 to reduce 
smoking prevalence, tobacco control actions involving 
legislation, education at worksites and schools, and 
the implementation of outpatient smoking cessation 
programs in health centers, but this has not been 
enforced. Now, more focus must be given to stop the 
flow of new smokers, from population groups such as 
youth and females. 
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